İnsandaki Demodex Akarı ile Göz ve Diğer Hastalıklar Arasındaki İlişki
Özet
İnsan yüzündeki kıl folikülleri ve yağ bezlerinde yaşayan kalıcı ektoparazitler olan Demodex folliculorum ve D. brevis akarlarının morfolojisi, yaşam döngüsü, teşhisi ve çeşitli hastalıklarla ilişkisi üzerine yapılmış bilimsel çalışmalar derlenmiştir. 3-4 haftalık yaşam döngüsüne sahip olan bu mikroskobik canlılar, standart yüzeyel deri biyopsisi veya kirpik epilasyonu yöntemleriyle teşhis edilmektedir. Kültür ortamında ex vivo olarak yaşatılamamaları immünopatogenezlerinin tam olarak anlaşılmasını zorlaştırmaktadır. Epidemiyolojik verilere göre dünya nüfusunun %80-90'ında bulunan bu akarlar; blefarit, kuru göz, akne ve rozasea gibi oküler ve dermatolojik rahatsızlıkların gelişiminde önemli roller üstlenmektedir. Demodex yoğunluğu ilerleyen yaşla ve cildin yağ oranıyla paralellik gösterirken, cinsiyetler arasında belirgin bir fark bulunmamaktadır. Özellikle kanser, diyabet, kronik böbrek yetmezliği ve Behçet hastalığı gibi bağışıklık sisteminin baskılandığı durumlarda, parazit popülasyonunda ve enfestasyon riskinde ciddi bir artış gözlenmektedir. Tedavisinde alkol ve antiseptiklere dirençli olan bu akarlara karşı en etkili ajan çay ağacı yağı ve onun aktif bileşeni olan Terpinen-4-ol'dür. Sonuç olarak, halk sağlığı açısından bu yaygın parazitin patogenezini, bulaş yollarını ve korunma yöntemlerini tam olarak aydınlatabilmek adına ileri düzey moleküler ve immünolojik kültür çalışmalarına ihtiyaç duyulmaktadır.
Scientific studies on the morphology, life cycle, diagnosis, and association with various diseases of Demodex folliculorum and D. brevis mites, which are permanent ectoparasites living in human hair follicles and sebaceous glands, have been reviewed. These microscopic organisms, which have a life cycle of 3-4 weeks, are diagnosed using standard superficial skin biopsy or eyelash epilation methods. The inability to keep them alive ex vivo in culture mediums makes it difficult to fully understand their immunopathogenesis. According to epidemiological data, these mites are found in approximately 80-90% of the world's population and play significant roles in the development of ocular and dermatological disorders such as blepharitis, dry eye, acne, and rosacea. While Demodex density runs parallel with advancing age and skin oiliness, no significant difference is observed between genders. Particularly in immunosuppressed conditions such as cancer, diabetes, chronic renal failure, and Behçet's disease, a serious increase in parasite population and infestation risk is detected. In its treatment, tea tree oil and its active component Terpinen-4-ol are the most effective agents against these mites, which are resistant to alcohol and antiseptics. Consequently, advanced molecular and immunological culture studies are required to fully elucidate the pathogenesis, transmission routes, and prevention methods of this common parasite in terms of public health.
Referanslar
Kokacya MH, Kaya OA, Copoglu US,et al. Prevalence of Demodex spp among alcohol-dependent patients. Cukurova Med J. 2016;41(2):259-63.
Elston CA, Elston DM. Demodex mites. Clin Dermatol. 2014;32(6):739-43.
Lacey N, Kavanagh K, Tseng SC. Under the lash: Demodex mites in human diseases. Biochem (Lond). 2009;31(4):2-6.
Luo X, Li J, Chen C,et al. Ocular Demodicosis as a Potential Cause of Ocular Surface Inflammation. Cornea. 2017;36 Suppl 1:S9-S14.
Inci M, Kaya OA, Inci M, et al. Investigating Demodex folliculorum in patients with urological cancer. Turkiye Parazitol Derg. 2012;36(4):208-10.
Litwin D, Chen W, Dzika E, et al. Human permanent ectoparasites; Recent advances on biology and clinical significance of Demodex mites: Narrative Review Article. Iran J Parasitol. 2017;12(1):12-21.
Chen W, Plewig G. Are Demodex mites principal, conspirator, accomplice, witness or bystander in the cause of rosacea? Am J Clin Dermatol. 2015;16(2):67-72.
Rusiecka-Ziolkowska J, Nokiel M, Fleischer M. Demodex - an old pathogen or a new one? Adv Clin Exp Med. 2014;23(2):295-8.
Emre S, Aycan OM, Atambay M,et al. What is the importance of Demodex folliculorum in Behcet's disease? Turkiye Parazitol Derg. 2009;33(2):158-61.
Aycan OM, Otlu GH, Karaman U, et al. Frequency of demodicosis in various patient and age groups. Turkiye Parazitol Derg. 2007;31(2):115-8.
Aycan-Kaya O, Atambay M, Daldal N. Prevalence of Demodex folliculorum and Demodex brevis in the eyelash follicles of healthy subjects. Kafkas Univ Vet Fak Derg. 2012;18:57-60.
Lacey N, Russell-Hallinan A, Powell FC. Study of Demodex mites: Challenges and solutions. J Eur Acad Dermatol Venereol. 2016;30(5):764-75.
Zhao YE, Guo N, Wu LP. The effect of temperature on the viability of Demodex folliculorum and Demodex brevis. Parasitol Res. 2009;105(6):1623-8.
Zhao YE, Guo N, Wu LP. Influence of temperature and medium on viability of Demodex folliculorum and Demodex brevis (Acari: Demodicidae). Exp Appl Acarol. 2011;54(4):421-5.
Humberto MS, Mendoza D, Luis EJ, et al. A novel technique for improving an in vitro culture of Demodex spp (Acari: Demodicidae). A pilot trial. Frontiers in Immunology 2015.
Tsai YJ, Chung WC, Wang LC, et al. The dog mite, Demodex canis: prevalence, fungal co-infection, reactions to light, and hair follicle apoptosis. J Insect Sci. 2011;11:76.
Palopoli MF, Minot S, Pei D, et al. Complete mitochondrial genomes of the human follicle mites Demodex brevis and D. folliculorum: novel gene arrangement, truncated tRNA genes, and ancient divergence between species. BMC Genomics. 2014;15:1124.
Daneshparvar A, Mowlavi G, Mirjalali H, et al. Molecular Characterization and Analysis of 16S Ribosomal DNA in Some Isolates of Demodex folicullorum. Iran J Parasitol. 2017;12(2):224-9.
Hu L, Yang Y, Zhao Y, et al. DNA barcoding for molecular identification of Demodex based on mitochondrial genes. Parasitol Res. 2017;116(12):3285-90.
Bitton E, Aumond S. Demodex and eye disease: a review. Clin Exp Optom. 2021;104(3):285-294.
Luo X, Li J, Chen C, et al. Ocular Demodicosis as a potential cause of ocular surface inflammation. Cornea 2017; 36: S9–S14.
Zhao YE, Wu LP, Hu L, et al. Association of blepharitis with Demodex: a meta‐analysis. Ophthalmic Epidemiol 2012; 19: 95–102.
Fromstein SR, Harthan JS, Patel J, et al. Demodex blepharitis: clinical perspectives. Clin Optom 2018; 10: 57–63.
Gutgesell VJ, Stern GA, Hood CI. Histopathology of meibomian gland dysfunction. Am J Ophthalmol 1982; 94: 383–387.
Liang L, Liu Y, Ding X, et al. Significant correlation between meibomian gland dysfunction and keratitis in young patients with Demodex brevis infestation. Br J Ophthalmol 2018; 102: 1098–1102.
Kheirkhah A, Casas V, Li W, et al. Corneal manifestations of ocular demodex infestation. Am J Ophthalmol 2007; 143: 743–749.
Tarkowski W, Owczynska M, Blaszczyk‐tyszka A , et al. Demodex mites as potential etiological factor in chalazion ‐ a study in Poland. Acta Parasitol 2015; 60: 777–783.
Ayyildiz T, Sezgin FM. The effect of ocular Demodex colonization on Schirmer test and OSDI scores in newly diagnosed dry eye patients. Eye Contact Lens 2020; 46: S39–S41.
Tarkowski W, Moneta‐wielgos J, Mlocicki D. Do Demodex mites play a role in pterygium development? Med Hypotheses 2017; 98: 6–10.
Jalbert I, Rejab S. Increased numbers of Demodex in contact lens wearers. Optom Vis Sci 2015; 92: 671–678.
Cheng AM, Sheha H, Tseng SC. Recent advances on ocular Demodex infestation. Curr Opin Ophthalmol. 2015;26(4):295-300.
Lopez-Ponce D, Zuazo F, Cartes C, et al. High prevalence of Demodex spp. infestation among patients with posterior blepharitis: correlation with age and cylindrical dandruff. Arch Soc Esp Oftalmol. 2017;92(9):412-8.
Alver O, Kivanc SA, Akova Budak B, et al. A Clinical Scoring System for Diagnosis of Ocular Demodicosis. Med Sci Monit. 2017;23:5862-9.
Rousta ST. Pediatric blepharokeratoconjunctivitis: is there a 'right' treatment? Curr Opin Ophthalmol. 2017;28(5):449-53.
Fromstein SR, Harthan JS, Patel J, et al. Demodex blepharitis: clinical perspectives. Clin Optom (Auckl). 2018;10:57-63.
Gao YY, Di Pascuale MA, Li W, et al. In vitro and in vivo killing of ocular Demodex by tea tree oil. Br J Ophthalmol. 2005;89(11):1468–1473.
Tighe S, Gao YY, Tseng SC. Terpinen-4-ol is the most active ingredient of tea tree oil to kill Demodex mites. Transl Vis Sci Technol. 2013;2:2.
Norgan AP, Pritt BS. Parasitic infections of the skin and subcutaneous tissues. Adv Anat Pathol. 2018;25(2):106-23.
Jarmuda S, O'Reilly N, Zaba R, et al. Potential role of Demodex mites and bacteria in the induction of rosacea. J Med Microbiol. 2012;61(Pt 11):1504-10.
Ozcelik S, Sumer Z, Degerli S, et al. The incidence of Demodex folliculorum in patients with chronic kidney deficiency. Turkiye Parazitol Derg. 2007;31(1):66-8.
Durmaz S, Erkan Y, Kaya OA, et al. Sociodemographic characteristics of patients with Demodex brevis and Demodex folliculorum infestation and its association with rosacea and Behçet's disease. Biomedical Research. 2015;26(3).
Chang YS, Huang YC. Role of Demodex mite infestation in rosacea: A systematic review and meta-analysis. J Am Acad Dermatol. 2017;77(3):441-7 e6.
Gokce C, Aycan-Kaya O, Yula E, et al. The effect of blood glucose regulation on the presence of opportunistic Demodex folliculorum mites in patients with type 2 diabetes mellitus. Journal of International Medical Research. 2013;41(5):1752-8.
Yagdiran Duzgun O, Aytekin S. Comparison of Demodex folliculorum density in haemodialysis patients with a control group. J Eur Acad Dermatol Venereol. 2007;21(4):480-3.
Yamashita LS, Cariello AJ, Geha NM, et al. Demodex folliculorum on the eyelash follicle of diabetic patients. Arq Bras Oftalmol. 2011;74(6):422-4.
Keskin Kurt R, Aycan Kaya O, Karateke A, Silfeler DB, Soylu Karapinar O, Akkoca AN, et al. Increased density of Demodex folliculorum mites in pregnancies with gestational diabetes. Med Princ Pract. 2014;23(4):369-72.
Zeytun E, Tilki E, Dogan S,et al. The effect of skin moisture, pH, and temperature on the density of Demodex folliculorum and Demodex brevis (Acari: Demodicidae) in students and staff of the Erzincan University, Turkey. Int J Dermatol. 2017;56(7):762-6.
Erbagci Z, Erbagci I, Erkilic S. High incidence of demodicidosis in eyelid basal cell carcinomas. Int J Dermatol. 2003;42(7):567-71.
Sun J, Gui X, He J, et al. The relationship between infestation of Demodex folliculorum and epidermal neoplasm on face. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi. 2005;23(6):428-31.
Seyhan ME, Karincaoglu Y, Bayram N, et al. Density of Demodex folliculorum in haematological malignancies. J Int Med Res. 2004;32(4):411-5.
Kaya S, Selimoglu MA, Kaya OA, et al. Prevalence of Demodex folliculorum and Demodex brevis in childhood malnutrition and malignancy. Pediatr Int. 2013;55(1):85-9.
Karincaoglu Y, Esrefoglu Seyhan M, Bayram N, et al. Incidence of Demodex folliculorum in patients with end stage chronic renal failure. Ren Fail. 2005;27(5):495-9.
Nara T, Katoh N, Inoue K,et al. Eosinophilic folliculitis with a Demodex folliculorum infestation successfully treated with ivermectin in a man infected with human immunodeficiency virus. Clin Exp Dermatol. 2009;34(8):e981-3.
Patrizi A, Neri I, Chieregato C,et al. Demodicidosis in immunocompetent young children: report of eight cases. Dermatology. 1997;195(3):239-42.
Dominey A, Rosen T, Tschen J. Papulonodular demodicidosis associated with AIDS. J Am Acad Dermatol. 1989;20:197–201.
Dokuyucu R, Kaya OA, Yula E,et al. The Presence of Demodex Folliculorum in Various Obese Groups According to BMI Levels. Arch Iran Med. 2016;19(3):210-4.
Kokacya MH. Demodex parasites in schizophrenia. J Clin Analyt Med. 2016;7(160):6-9.
Liaqat M, Wilson LH, Wada D, et al. Neutrophilic sebaceous adenitis with intralobular Demodex mites: a case report and review of the literature. Am J Dermatopathol. 2015;37(4):315-8.
Benk Silfeler D, Keskin Kurt R, Kaya OA, et al. Demodex folliculorum in polycystic ovary syndrome patients. Eur Rev Med Pharmacol Sci. 2015;19(7):1141-5.
Cevik C, Kaya OA, Akbay E, et al. Investigation of demodex species frequency in patients with a persistent itchy ear canal treated with a local steroid. J Laryngol Otol. 2014;128(8):698-701.
Aytekin S. Outbreak of Demodex folliculitis on the face and upper trunk during 311-nm UVB therapy for psoriasis. J Eur Acad Dermatol Venereol. 2004;18:236–8.
Ferrer L, Ravera I, Silbermayr K. Immunology and pathogenesis of canine demodicosis. Vet Dermatol. 2014;25(5):427-e65.
Akilov OE, Mumcuoglu KY. Association between human demodicosis and HLA class I. Clin Exp Dermatol. 2003;28(1):70-3.
